The 23rd edition of BioAsia 2026 brings global leaders together to shape the next phase of healthcare and life sciences innovation. In the panel “Catalysts that Actually Scale: Science, Software and Supply��, experts including Prof. Kil-To Chong, Dr. Despina Solomonidou, Mr. Eammon Warren, Dr. Peter Owotoki, Ms. Rashmi Kumar and Dr. Kenneth Barr, moderated by Mr. Shriram Chary, highlighted faster discovery, AI-enabled drug development, and stronger R&D and manufacturing integration to scale innovation through value-driven outcomes.
If you have not registered yet, secure your spot and be part of the conversations shaping the future of healthcare: https://t.co/0Q7kiCankj
For detailed agenda, please visit: https://t.co/Nl9ByhcK0d
#BioAsia #TechBioUnleashed #LifeSciencesSummit #GlobalHealthcare #lifesciences #BioAsia2026 #aihealthcareindia #InnovationInTechBio #futureofhealthcare
@THSTIFaridabad@iitdelhi Congratulations to both the organizations and feels wonderful to see #THSTI soar new heights. Best wishes to Dr Supratik Das and the team involved.
India at the Forefront of Biotech & Space Medicine
In a special address at BIRAC’s 13th Foundation Day, Dr. Jitendra Singh, Hon’ble Minister of State (Independent Charge) for S&T, reaffirmed the government’s commitment to advancing science, technology, and the bioeconomy.
@amazonIN you dont write the product compatibility and the technical person comes says that the product is incompatible and now as a customer i am in between amazon and the company with a useless product and a dent of 4.5K. i have recorded the entire conversation with your
@amazonIN you dont write the product compatibility and the technical person comes says that the product is incompatible and now as a customer i am in between amazon and the company with a useless product and a dent of 4.5K. i have recorded the entire conversation with your
The 3rd #G20India Health WG Meeting concluded under the India Presidency. Collaborative R&D on #vaccines#therapeutics and #diagnostics (VTD) as Medical Countermeasure Coordination Platform was proposed as preparative action against future diseases https://t.co/ge8388Pc8C
Mr Himanshu Gupta @guptah21, Co-founder and CEO of ClimateAi @climateai, speaks of his imminent plans of investing in India after having participated in a roundtable of business leaders and investors with Union Finance Minister Smt. @nsitharaman, in Washington DC.
USIBC welcomes the new National Medical Devices Policy. Our members appreciated the opportunity to engage with government officials during our #LifeSciences mission last week, and look forward to continuing discussions on how to strengthen India's #medtech sector 🦿⚕️🩻
Wonderful exchange of ideas on U.S.-India healthcare cooperation with Honorable Health Minister @mansukhmandviya. We discussed ways to promote #innovation in in-vitro diagnostics, ensure access to high quality medical devices, and strengthen joint efforts in R&D 🦾👩🏽🔬🧫
Sweeping ambition and compelling vision in @PMOIndia@narendramodi remarks about India's energy transition and growth plans at #IndiaEnergyWeek in Bengaluru today. Just one example: Millions of solar cookstoves will help alleviate the plight of so many low income households. 🙏🏼
Thanks @JohnCabeca@USPTO for joining the panel on IP @USIBC India-U.S. Tech Conclave. USIBC along with its members would continue to work with your office and with Indian Patent Office for streamlining #IntellectualProperty experiences for life sciences companies in India
U.S.-India collaborations in Biotechnology and cutting-edge Biomedical Research & Manufacturing has the immense potential to bring into offerings for patients and caregivers the next generation of healthcare technologies in #Moleculardiagnostics, #DrugDiscovery, #surgicalrobotics
USIBC held en engaging meeting with Dr. Rajesh Gokhale, Secretary, @DBTIndia at the @USChamber today, where members had the opportunity to discuss U.S.-India cooperation in #biotechnology and avenues to build out our high-trust #innovation ecosystem.
Diagnostic tech is driving the ability to identify, isolate and treat to reduce the spread of infectious diseases. The introduction of reliable rapid antigen tests illustrated the benefit of decentralized technologies at the point of care. Sanjeev Johar, @AbbottNews
Women should not just fill quotas in boardrooms but significantly contribute to organisational strategy, @smritiirani said at the US-India Business Council’s (USIBC) India Ideas Summit 2022.
#FEAspire#msme
https://t.co/uyXO88QXOY